Ainos (AIMD) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$13,600.00

Revenue (quarter)

$152.00

Revenue growth (year over year)

−96.74%

Gross profit (trailing twelve months)

$10,708.00

Gross margin

78.74%

Net income (trailing twelve months)

−$14.5M

Net income (quarter)

−$4.6M

Net income growth (year over year)

−12.48%

Net margin

−106283.32%

Return on equity

−196.30%

EPS (trailing twelve months)

−$2.49

Book value per share

$0.44

P/E (trailing twelve months)

—

Price to book

2.27

Debt to assets

83.21%

Payout ratio

—

Dividend yield

—

Company profile

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

• Is Ainos (AIMD) profitable?

  No. Ainos reported a net loss of $14.5M over the trailing twelve months.

• How much revenue does Ainos (AIMD) make?

  Ainos generated $13,600.00 in revenue over the trailing twelve months, down 96.74% year over year.

• How do I buy stock in Ainos (AIMD)?

  AIMD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.